logo.jpg
Lexicon Announces Outcome of FDA Advisory Committee for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease
October 31, 2024 18:54 ET | Lexicon Pharmaceuticals, Inc.
THE WOODLANDS, Texas, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the outcome of the U.S. Food and Drug Administration (FDA) Endocrinologic and...
Tileshop Logo Image.jpg
The Tile Shop to Host Third Quarter 2024 Earnings Conference Call
October 31, 2024 17:00 ET | Tile Shop Holdings, Inc.
MINNEAPOLIS, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Tile Shop Holdings, Inc. (Nasdaq: TTSH) (the “Company”), a specialty retailer of natural stone tiles, man-made and luxury vinyl tiles, setting and...
Clipboard01.jpg
CPS Announces Third Quarter 2024 Earnings
October 31, 2024 16:30 ET | Consumer Portfolio Services, Inc.
Revenues of $100.6 million compared to $92.1 million in the prior year periodNet income of $4.8 million, or $0.20 per diluted shareTotal portfolio balance of $3.330 billion, highest in company...